ClinicalTrials HQ

Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated with Targeted Therapy

Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated with Targeted Therapy

Recruiting · NCT06130787 · Registry updated 2024-09-27
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Value of Biological Age, in Addition to Individual Frailty, for Personalising the Management of Cancer Treated with Targeted TherapyChronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone marrow disorder, hematologic disorder, leukemia, myeloid leukemia, neoplasmRecruitingNot applicable2024-09-27NCT06130787

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
University Hospital, Clermont-Ferrand171

17 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Centre Hospitalier Emile RouxLe Puy-en-VelayFrance7
Centre Léon BérardLyonFrance71
CHRU LilleLilleFrance32
CHU Annecy-GenevoisAnnecyFrance1
CHU CaenCaenFrance48
CHU CréteilCréteilFrance2
CHU de Clermont-FerrandClermont-FerrandFrance37
CHU Grenoble AlpesGrenobleFrance25
CHU LimogesLimogesFrance42
CHU NancyNancyFrance24
CHU RennesRennesFrance57
CHU Saint-EtienneSaint-EtienneFrance22
CHU VersaillesVersaillesFrance1
Groupe Hospitalier Paris Saclay - Site de BicêtreParisFrance1
Institut BergoniéBordeauxFrance47
Institut Paoli-CalmettesMarseilleFrance23
Institut Universitaire du Cancer de Toulouse - OncopoleToulouseFrance7